X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (30663) 30663
Patent (3788) 3788
Publication (3197) 3197
Book Review (420) 420
Book / eBook (179) 179
Book Chapter (114) 114
Conference Proceeding (92) 92
Newspaper Article (44) 44
Magazine Article (13) 13
Newsletter (10) 10
Dissertation (7) 7
Web Resource (7) 7
Data Set (4) 4
Trade Publication Article (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29647) 29647
index medicus (15915) 15915
male (13017) 13017
female (12563) 12563
middle aged (9776) 9776
adult (8525) 8525
aged (7459) 7459
oncology (6813) 6813
rituximab (6392) 6392
hematology (5770) 5770
animals (4588) 4588
immunology (3962) 3962
treatment outcome (3930) 3930
human necessities (3788) 3788
hygiene (3786) 3786
medical or veterinary science (3783) 3783
preparations for medical, dental, or toilet purposes (3741) 3741
peptides (3723) 3723
chemistry (3720) 3720
metallurgy (3604) 3604
organic chemistry (3567) 3567
antibodies, monoclonal - therapeutic use (3563) 3563
pathology (3504) 3504
cancer (3497) 3497
immunohistochemistry (3429) 3429
research (3391) 3391
lymphomas (3366) 3366
care and treatment (3105) 3105
antibodies, monoclonal, murine-derived (2835) 2835
aged, 80 and over (2763) 2763
adolescent (2685) 2685
therapy (2638) 2638
diagnosis (2581) 2581
expression (2498) 2498
prognosis (2471) 2471
health aspects (2457) 2457
chemotherapy (2420) 2420
lymphocytes (2366) 2366
antineoplastic combined chemotherapy protocols - therapeutic use (2351) 2351
flow cytometry (2320) 2320
lymphoma (2320) 2320
non-hodgkins-lymphoma (2282) 2282
b-lymphocytes - immunology (2265) 2265
disease (2197) 2197
mice (2185) 2185
antineoplastic agents - therapeutic use (2175) 2175
specific therapeutic activity of chemical compounds ormedicinal preparations (2161) 2161
child (2121) 2121
immunophenotyping (2050) 2050
immunotherapy (2015) 2015
diagnosis, differential (1951) 1951
biopsy (1933) 1933
transplantation (1912) 1912
medicine, research & experimental (1837) 1837
microbiology (1718) 1718
medicine (1706) 1706
young adult (1705) 1705
research article (1631) 1631
b-cell lymphoma (1600) 1600
hemic and lymphatic diseases (1583) 1583
analysis (1558) 1558
article (1541) 1541
retrospective studies (1533) 1533
antigens, cd20 - immunology (1530) 1530
tumors (1520) 1520
biochemistry (1515) 1515
risk factors (1505) 1505
anti-cd20 monoclonal-antibody (1491) 1491
rheumatology (1462) 1462
leukemia (1448) 1448
abridged index medicus (1428) 1428
surgery (1407) 1407
b cells (1405) 1405
t cells (1401) 1401
cell biology (1380) 1380
chronic lymphocytic-leukemia (1367) 1367
patients (1360) 1360
physiological aspects (1343) 1343
proteins (1332) 1332
antigens (1327) 1327
genetic aspects (1308) 1308
apoptosis (1303) 1303
monoclonal antibodies (1282) 1282
pharmacology & pharmacy (1282) 1282
enzymology (1265) 1265
beer (1262) 1262
antibodies (1259) 1259
mutation or genetic engineering (1259) 1259
spirits (1259) 1259
vinegar (1259) 1259
wine (1259) 1259
gene expression (1255) 1255
child, preschool (1233) 1233
drug therapy (1233) 1233
multidisciplinary sciences (1203) 1203
immunoglobulins (1174) 1174
follow-up studies (1171) 1171
antibodies, monoclonal, murine-derived - therapeutic use (1165) 1165
cell line, tumor (1164) 1164
antibodies, monoclonal - administration & dosage (1135) 1135
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (140) 140
Collection Dvlpm't (Acquisitions) - Closed Orders (13) 13
Online Resources - Online (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
UofT at Mississauga - Stacks (6) 6
Humber River Regional Hospital - Church Stacks (5) 5
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (4) 4
Humber River Regional Hospital - Finch Stacks (4) 4
Providence Healthcare - Stacks (4) 4
Scarborough Hospital - General (4) 4
Toronto East General Hospital - Stacks (4) 4
UTL at Downsview - May be requested (4) 4
St. Michael's Hospital - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Credit Valley Hospital - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Robarts - Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Trillium Health Centre - Stacks (2) 2
Baycrest Hospital - Course Reserves (1) 1
Credit Valley Hospital - Reference (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Course Reserves (1) 1
Gerstein Science - May be requested (1) 1
Humber River Regional Hospital - Departmental Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Providence Healthcare - Reference (1) 1
St Josephs Health Centre - Reference (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Sunnybrook Stacks (1) 1
Women's College Hospital - Pharmacy (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32738) 32738
French (1159) 1159
Chinese (731) 731
German (493) 493
Japanese (462) 462
Spanish (437) 437
Russian (251) 251
Korean (151) 151
Portuguese (122) 122
Polish (56) 56
Norwegian (47) 47
Danish (34) 34
Czech (29) 29
Hungarian (28) 28
Hebrew (27) 27
Croatian (26) 26
Greek (26) 26
Italian (24) 24
Serbian (23) 23
Slovenian (23) 23
Ukrainian (23) 23
Lithuanian (11) 11
Arabic (9) 9
Finnish (8) 8
Romanian (7) 7
Turkish (7) 7
Dutch (6) 6
Bulgarian (3) 3
Swedish (3) 3
Slovak (2) 2
Estonian (1) 1
Icelandic (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 12/2015, Volume 171, Issue 5, pp. 763 - 775
Obinutuzumab is a novel glycoengineered Type‐ II CD 20 monoclonal antibody. CD 20 is expressed in approximately 100% of children and adolescents with Burkitt... 
ALL | rituximab‐sensitive | rituximab‐resistant | pre‐B | obinutuzumab | rituximab | Rituximab | Obinutuzumab | Pre-B-ALL | Rituximab-sensitive BL | Rituximab-resistant BL | pre-B-ALL | NATURAL-KILLER-CELLS | ONCOLOGY GROUP-REPORT | rituximab-sensitive BL | rituximab-resistant ill | PHASE I/II | CHEMOTHERAPY PLUS RITUXIMAB | CHILDREN | IN-VITRO | ANTI-CD20 MONOCLONAL-ANTIBODY | NON-HODGKIN-LYMPHOMA | CHRONIC LYMPHOCYTIC-LEUKEMIA | RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA | HEMATOLOGY | Neoplasm Transplantation | Apoptosis - drug effects | Humans | Transplantation, Heterologous | Rituximab - pharmacology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Animals | Caspases - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Survival Analysis | Cell Line, Tumor | Caspases - drug effects | Lysosomal-Associated Membrane Protein 1 - metabolism | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Killer Cells, Natural - drug effects | Mice | Interferon-gamma - biosynthesis | Molecular Targeted Therapy - methods | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Evaluation | Cell death | Patient outcomes | Monoclonal antibodies | Biochemistry | Comparative analysis | Antineoplastic agents | Burkitt's lymphoma
Journal Article
Blood, ISSN 0006-4971, 06/2010, Volume 115, Issue 22, pp. 4393 - 4402
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 11/2012, Volume 70 Suppl 8, p. 170
Journal Article
中国药理学报:英文版, ISSN 1671-4083, 2018, Volume 39, Issue 2, pp. 261 - 274
Melanoma is the deadliest type of skin cancer. CD20+ melanoma stem cells (CSCs) are pivotal for metastasis and initiation of melanoma. Therefore, selective... 
类脂化合物;聚合物;干细胞;装载;压制;CSC;治疗学;细胞毒素 | CD20 | melanoma | salinomycin | nanoparticles | cancer stem cells | aptamers | DRUG-DELIVERY | MONOCLONAL-ANTIBODY | OPPORTUNITIES | CHEMISTRY, MULTIDISCIPLINARY | NANOMEDICINE STRATEGIES | TARGETED TREATMENT | IN-VITRO | LIVER-CANCER CELLS | THERAPY | LYMPHOMA | PHARMACOLOGY & PHARMACY | Lecithins - toxicity | Lecithins - metabolism | Drug Carriers - therapeutic use | Nanoparticles - chemistry | Neoplastic Stem Cells - drug effects | Humans | Drug Carriers - toxicity | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Polyethylene Glycols - therapeutic use | Drug Carriers - chemistry | Lecithins - chemistry | Nanoparticles - therapeutic use | Nanoparticles - metabolism | Antineoplastic Agents - pharmacology | Pyrans - pharmacology | Pyrans - therapeutic use | Polyethylene Glycols - metabolism | Drug Carriers - metabolism | Aptamers, Nucleotide - toxicity | Lecithins - therapeutic use | Aptamers, Nucleotide - chemistry | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - metabolism | Polyethylene Glycols - toxicity | Nanoparticles - toxicity | Particle Size | Xenograft Model Antitumor Assays | Animals | Melanoma - drug therapy | Mice, Inbred BALB C | Antigens, CD20 - chemistry | Drugs | Drug delivery systems | Effectiveness | Toxicity | Melanoma | Stem cell transplantation | Cytotoxicity | Lipids | Drug delivery | Skin cancer | Metastases | Nanoparticles | Salinomycin | Allografts | Cell lines | Stem cells | Aptamers | Xenografts | CD20 antigen | Skin | Conjugation | Polymers | Cancer | Original
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4462 - 4469
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2018, Volume 180, Issue 6, pp. 808 - 820
Journal Article
Journal of Immunology, ISSN 0022-1767, 11/2010, Volume 185, Issue 9, pp. 4977 - 4982
Journal Article